Identification of Baicalin as an Immunoregulatory Compound by Controlling TH17 Cell Differentiation
2011

Baicalin's Role in Controlling TH17 Cell Differentiation

Sample size: 6 publication 10 minutes Evidence: moderate

Author Information

Author(s): Yang Ji, Yang Xue, Chu Yiwei, Li Ming

Primary Institution: Zhongshan Hospital, Fudan University, Shanghai, China

Hypothesis

Baicalin might inhibit inflammatory injuries by suppressing effector TH17 cells.

Conclusion

Baicalin can inhibit TH17 cell differentiation and may serve as a therapeutic agent for TH17-mediated inflammatory diseases.

Supporting Evidence

  • Baicalin inhibited TH17 cell differentiation in vitro and in vivo.
  • Treatment with Baicalin reduced TH17 cell infiltration into the kidneys of lupus-prone mice.
  • Baicalin up-regulated Foxp3 expression while down-regulating RORγt-mediated IL-17 expression.

Takeaway

Baicalin is a natural compound that helps stop certain immune cells from causing inflammation, which can help treat diseases like lupus.

Methodology

The study involved in vitro and in vivo experiments using TH17 cell cultures and lupus-prone mice to assess the effects of Baicalin on TH17 differentiation.

Potential Biases

Potential bias may arise from the use of specific mouse models that may not fully represent human conditions.

Limitations

The study primarily focused on TH17 cells and did not explore the effects of Baicalin on other immune cell types in detail.

Participant Demographics

Lupus-prone MRL/lpr mice were used in the in vivo studies.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1371/journal.pone.0017164

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication